Immediate Impact
23 standout
Citing Papers
Management of chronic myeloid leukemia in 2023 – common ground and common sense
2023 Standout
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
2023 Standout
Works of Giuseppina Loglisci being referenced
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
2011
“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Giuseppina Loglisci | 188 | 129 | 50 | 57 | 22 | 273 | |
| Elisa Cerqui | 197 | 80 | 90 | 58 | 18 | 278 | |
| R. de Paz | 132 | 45 | 39 | 56 | 21 | 274 | |
| H. Deicher | 86 | 56 | 38 | 53 | 26 | 327 | |
| Douglas Tremblay | 187 | 173 | 86 | 41 | 20 | 319 | |
| Ambra Di Veroli | 219 | 114 | 86 | 37 | 30 | 321 | |
| J.G. Fuzibet | 149 | 60 | 80 | 62 | 36 | 328 | |
| Vincenzo Federico | 147 | 80 | 40 | 67 | 26 | 238 | |
| Durjoy K. Shome | 141 | 80 | 31 | 19 | 31 | 225 | |
| Chiara Frairia | 141 | 86 | 84 | 95 | 24 | 284 | |
| Said Mohamed | 120 | 58 | 43 | 57 | 27 | 248 |
All Works
Loading papers...